Drug Type Autologous CAR-T |
Synonyms CARsT therapy TCRCure Biotech, Retroviral vector-transduced anti-ALPP CARs-T therapy, TC-A101 |
Target |
Action inhibitors |
Mechanism ALPP inhibitors(alkaline phosphatase, placental inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | China | 01 Dec 2020 | |
Endometrial Carcinoma | Preclinical | China | 30 Dec 2020 | |
Ovarian Epithelial Carcinoma | Preclinical | China | 30 Dec 2020 | |
Testicular Neoplasms | Preclinical | China | 30 Dec 2020 | |
Uterine Cervical Cancer | Preclinical | China | 30 Dec 2020 |